. 2025 Oct 30;5(6):677–697. doi: 10.21873/cdp.10484

Table IV. Multivariate Cox regression analyses for DSS among the p62^highALDH1A3^high, p62^highALDH1A3^low, p62^lowALDH1A3^high and p62^lowALDH1A3^low groups of patients with luminal breast cancer subtypes treated with or without tamoxifen in TCGA dataset.

N.D.: Not determined; TCGA: The Cancer Genome Atlas; DSS: disease-specific survival; ALDH1A3: aldehyde dehydrogenase 1 family member A3. The hazard ratio of the p62^highALDH1A3^high group relative to the p62^highALDH1A3^low, p62^lowALDH1A3^high and p62^lowALDH1A3^low groups was adjusted using age as a confounding factor, as estimated using the Cox proportional hazard model. Significant differences are shown in bold.

Table IV. Multivariate Cox regression analyses for DSS among the p62highALDH1A3high, p62highALDH1A3low, p62lowALDH1A3high and p62lowALDH1A3low groups of patients with luminal breast cancer subtypes treated with or without tamoxifen in TCGA dataset.

Table IV. Multivariate Cox regression analyses for DSS among the p62^highALDH1A3^high, p62^highALDH1A3^low, p62^lowALDH1A3^high and p62^lowALDH1A3^low groups of patients with luminal breast cancer subtypes treated with or without tamoxifen in TCGA dataset.